Chau Cheng

Chau Cheng currently serves as Vice President at CG Oncology since August 2024. Prior to this role, Chau Cheng held the position of Vice President at Immunovant from September 2022 to August 2024. Chau Cheng also served as VP of Investor Relations & Corporate Communications at CytomX Therapeutics from December 2020 to September 2022 and as Senior Director of Investor Relations at Immunomedics from June 2004 to December 2020. Academic qualifications include a Master of Business Administration in Finance from New York University and a Doctor of Philosophy in Organic Chemistry from The Open University.